Inventor · disambiguated record
Yoshiyasu Shitori
Also filed as: SHITORI YOSHIYASU
26 granted patents·233 citations·filing 1982–1991
96Inventor score
Top patents by PatentIndex Score
26 records- 0184US4694076ASialic acid derivativesKANTO ISHI PHARMA CO LTD·Filed 1984·Granted Sep 15, 1987·24 cites·14 claims
- 0276US4797477AProcess for preparing sialic acid derivativesKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Jan 10, 1989·27 cites·7 claims
- 0372US4698332AExpectorantKANTO ISHI PHARMA CO LTD·Filed 1985·Granted Oct 6, 1987·22 cites·8 claims
- 0466US4914195AProcess for preparing N-acetylneuraminic acid derivativesKANTO ISHI PHARMA CO LTD·Filed 1984·Granted Apr 3, 1990·11 cites·6 claims
- 0564US4968786ASialic acid derivatives, galactose derivatives and method for producing the sameRIKAGAKU KENKYUSHO·Filed 1985·Granted Nov 6, 1990·12 cites·9 claims
- 0663US4918177ASialic acid derivatives having active carbonyl groupKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Apr 17, 1990·9 cites·36 claims
- 0763US4880572AUn-natural ceramide related compounds and preparation thereofKANTO ISHI PHARMA CO LTD·Filed 1988·Granted Nov 14, 1989·6 cites·17 claims
- 0862US4447600AN-Acetylneuraminic acid derivatives and the preparation thereofKANTO ISHI PHARMA CO LTD·Filed 1982·Granted May 8, 1984·9 cites·5 claims
- 0961US4950750AGlycolipid containing N-glycolylneuraminic acid and method of producing the sameKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Aug 21, 1990·11 cites·19 claims
- 1059US5101026AGanglioside related compounds and method of producing the sameKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Mar 31, 1992·9 cites·3 claims
- 1159US5023239ASialosyl cholesterol, process for producing the same, and neuropathy remedy comprising the sameKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Jun 11, 1991·9 cites·9 claims
- 1254US4774326AProcess for preparing N-glycolylneuraminic acid derivativesKANTO ISHI PHARMA CO LTD·Filed 1986·Granted Sep 27, 1988·8 cites·6 claims
- 1354US4663443AN-substituted neuraminic acid derivativesKANTO ISHI PHARMA CO LTD·Filed 1985·Granted May 5, 1987·6 cites·4 claims
- 1453US4691012ASialic acid derivative and process for preparing the sameKANTO ISHI PHARMA CO LTD·Filed 1985·Granted Sep 1, 1987·6 cites·16 claims
- 1552US5015631ARepairing agent for cells and tissuesKANTO ISHI PHARMA CO LTD·Filed 1988·Granted May 14, 1991·6 cites·2 claims
- 1652US4730058ASialosylceramides and production method thereofKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Mar 8, 1988·7 cites·14 claims
- 1751US5158886AMonoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereofKANTO ISHI PHARMA CO LTD·Filed 1988·Granted Oct 27, 1992·9 cites·6 claims
- 1850US4990603ASialic acid derivatives and process thereforKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Feb 5, 1991·6 cites·11 claims
- 1950US4774327AN-glycolylneuraminic acid derivativeKANTO ISHI PHARMA CO LTD·Filed 1986·Granted Sep 27, 1988·6 cites·3 claims
- 2050US4751290ASialosylcerebrosidesRIKAGAKU KENKYUSHO·Filed 1986·Granted Jun 14, 1988·5 cites·9 claims
- 2149US4675391AGlycoside derivativesKANTO ISHI PHARMA CO LTD·Filed 1986·Granted Jun 23, 1987·5 cites·4 claims
- 2247US5057605ASialocylglycerolipids and method for preparing the sameKANTO ISHI PHARMA CO LTD·Filed 1988·Granted Oct 15, 1991·4 cites·13 claims
- 2344US5126330ASialosyl cholesterol and neuropathy remedy comprising the sameKANTO ISHI PHARMA CO LTD·Filed 1991·Granted Jun 30, 1992·4 cites·2 claims
- 2440US5141864AMonoclonal antibody recognizing alpha 2→3 bondsKANTO ISHI PHARMA CO LTD·Filed 1988·Granted Aug 25, 1992·2 cites·5 claims
- 2537US4990604AAsialoganglioside related compoundsRIKAGAKU KENKYUSHO·Filed 1986·Granted Feb 5, 1991·3 cites·6 claims
- 2633US4788200AMethod and composition for treating arteriosclerosisKANTO ISHI PHARMA CO LTD·Filed 1987·Granted Nov 29, 1988·7 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Yoshiyasu Shitori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →